Replies to post #177627 on Biotech Values

[biocqr]

PFE > interesting factoid...

Despite having spent some $240bn on three big acquisitions since 2000, its market capitalisation is just $185bn today. Meanwhile the Dow Jones index is more than 40 per cent higher.

The real choice that AstraZeneca faces
http://www.ft.com/intl/cms/s/2/207666be-d78c-11e3-b381-00144feabdc0.html#axzz31YDe6Yxc